[go: up one dir, main page]

UA95686U - MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM - Google Patents

MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM

Info

Publication number
UA95686U
UA95686U UAU201411372U UAU201411372U UA95686U UA 95686 U UA95686 U UA 95686U UA U201411372 U UAU201411372 U UA U201411372U UA U201411372 U UAU201411372 U UA U201411372U UA 95686 U UA95686 U UA 95686U
Authority
UA
Ukraine
Prior art keywords
preposition
medicine
surface form
disease therapy
active substance
Prior art date
Application number
UAU201411372U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Vadym Mordukhovych Pohrebynskyi
Valerii Kostiantynovych Pechaiev
Volodymyr Petrovych Yemelianenko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201411372U priority Critical patent/UA95686U/en
Publication of UA95686U publication Critical patent/UA95686U/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Лікарський засіб для терапії захворювань передміхурової залози в формі супозиторія, що містить діючу речовину - біологічно активний засіб (БАЗ) "Простатилен" (екстракт з тканини передміхурової залози статевозрілих бичків) та наповнювач. Як діючу речовину він додатково містить тамсулозину гідрохлорид та інертний наповнювач (основу).Drug for the treatment of prostate diseases in the form of a suppository containing the active substance - biologically active agent (BAZ) "Prostatylene" (prostate tissue extract of sexually mature bull calves) and filler. As an active substance it additionally contains tamsulosin hydrochloride and an inert filler (base).

UAU201411372U 2014-10-17 2014-10-17 MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM UA95686U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201411372U UA95686U (en) 2014-10-17 2014-10-17 MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201411372U UA95686U (en) 2014-10-17 2014-10-17 MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM

Publications (1)

Publication Number Publication Date
UA95686U true UA95686U (en) 2014-12-25

Family

ID=52680891

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201411372U UA95686U (en) 2014-10-17 2014-10-17 MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM

Country Status (1)

Country Link
UA (1) UA95686U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017091182A1 (en) * 2015-11-26 2017-06-01 Общество С Ограниченной Ответственностью "Фармацевтический Завод "Биофарма" A medicine in the form of "prostex" suppository for prevention and treatment of prostatic diseases, and method for producing thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017091182A1 (en) * 2015-11-26 2017-06-01 Общество С Ограниченной Ответственностью "Фармацевтический Завод "Биофарма" A medicine in the form of "prostex" suppository for prevention and treatment of prostatic diseases, and method for producing thereof

Similar Documents

Publication Publication Date Title
MX2024010140A (en) NEW METHODS.
CL2018000706A1 (en) Derivatives of pyrazolopyrimidine as btk inhibitors for the treatment of cancer.
MX2022011334A (en) Treatment of fabry disease in ert-naãve and ert-experienced patients.
MX393855B (en) COMBINATION THERAPY INCLUDING A RAF INHIBITOR AND TRAMETINIB
MX379297B (en) TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE.
MX2017014338A (en) Targeted selection of patients for treatment with cortistatin derivatives.
BR112015006176A8 (en) cancer treatment method in an individual in need of treatment
JOP20200231A1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
MX2017000628A (en) Methods for treating high cardiovascular risk patients with hypercholesterolemia.
MX2019003134A (en) Combination therapy.
MX2017007497A (en) Proton-binding polymers for oral administration.
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
NI201700024A (en) ANAMORELIN-BASED MEDICAL TREATMENTS
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
MX382776B (en) USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY.
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
CY1119532T1 (en) (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
MX2022000746A (en) DIMETHYL FUMARATE AND VACCINATION REGIMENS.
EA202191165A1 (en) ELACESTRANT IN COMBINATION WITH ABEMACYCLIBUS IN WOMEN WITH BREAST CANCER
MX383682B (en) TREATMENT FOR BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL TAXANE FORMULATION, A NON-LIPOSOMAL TAXANE FORMULATION, AND AN ADDITIONAL ACTIVE AGENT.
UA116499C2 (en) (R) -PIRLINDOL AND ITS PHARMACEUTICALLY ACCEPTED SALTS FOR MEDICINAL USE
UA95686U (en) MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM
UA95687U (en) MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM
EA201890014A1 (en) THERAPEUTIC COMPOSITIONS CONTAINING DIPYRIDAMOL, KITS FOR TREATMENT, CONTAINING THESE COMPOSITIONS, AND METHODS OF THEIR MANUFACTURE